The central goal of this proposal is to achieve further insight into the molecular events responsible for generation of specific cell types and homeostatic regulation of trophic factors in the anterior pituitary gland. The cloning and functional analysis of several cell-specific transcription factors, and the identification of a large family of tissue-specific transcription factors containing a novel motif, the POU- domain, permits analysis of strategies of transcriptional activation and regulation of neuroendocrine genes and the mechanisms of establishing distinct cellular phenotypes within an organ. The functions of the pituitary-specific factor, Pit-1, in pituitary development will be investigated by detailed ontogenic analysis of genetic dwarf mice with defects in the Pit-1 gene, and by targeted ecotopic expression in transgenic animals. Additional Pit-1, DNA contacts, the nature of the Pit-1 response element, and a full characterization of the mutative trans- activation domains will be performed in mammalian cells and in yeast. Protein-protein interactions and the effects of hormone-induced covalent modifications of Pit-1 will be evaluated with respect to DNA binding and transcriptional activation. The combinational code responsible for cell-specific patterns of activation and restriction of growth hormone and prolactin gene expression will be studied by characterizing and cloning additional factors exerting functions on expression of the promoter and enhancer elements of these genes. Two such factors that have been identified and cloned will be characterized in detail. The cis-active elements responsible for activation of the Pit-1 gene in thyrophs, lactotrophs, and somatotrophs will be established both by transgenic animal and cell transfection studies, and the nature of the transacting factors will be investigated. We have recently defined a novel calcium-mediated pathway of transcriptional regulation dependent upon the actions of a calcium, calmodulin-dependent protein kinase. We plan to identify the responsive cis-active elements in the rat prolactin gene, and other transcription units, and to clone and characterize the responsible transacting factor(s), utilizing constitutive variants of the calcium, calmodulin-dependent protein kinase alpha created by mutagenesis. The molecular basis of DNA site- specific positive and negative regulation of gene expression will be further defined by evaluating the role of protein-protein interaction domains and various high-affinity binding sites for several classes of transcription factors, including ligand-dependent transcription factors that prevent them from acting as response elements. The structural domains of the T3 receptor and Pit-1 that dictate element-dependent negative transcriptional responses will be defined to the level of single amino acid residues. Both retinoic acid and thyroid hormone exert important functions in growth hormone and prolactin gene expression. The retinoic acid receptor appears to require a series of factors distinct in different cell types, to form high-affinity heterodimers required to bind to retinoic acid response elements. These factors will be purified, characterized, and encoding cDNAs in pituitary cells will be cloned using several strategies in order to permit study of their putative functional roles in morphogenesis and transcriptional regulation. These studies should provide insights into the complex interactions of regulatory factors that control development and homeostatic characteristics of specific cell types within an endocrine organ.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK018477-20
Application #
2137195
Study Section
Endocrinology Study Section (END)
Project Start
1977-06-01
Project End
1996-03-31
Budget Start
1995-07-01
Budget End
1996-03-31
Support Year
20
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Kim, Hong Sook; Tan, Yuliang; Ma, Wubin et al. (2018) Pluripotency factors functionally premark cell-type-restricted enhancers in ES cells. Nature 556:510-514
Wang, Jianxun; Saijo, Kaoru; Skola, Dylan et al. (2018) Histone demethylase LSD1 regulates hematopoietic stem cells homeostasis and protects from death by endotoxic shock. Proc Natl Acad Sci U S A 115:E244-E252
Tan, Yuliang; Jin, Chunyu; Ma, Wubin et al. (2018) Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program. Mol Cell 71:526-539.e8
Cardamone, Maria Dafne; Tanasa, Bogdan; Cederquist, Carly T et al. (2018) Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation. Mol Cell 69:757-772.e7
Yang, Feng; Ma, Qi; Liu, Zhijie et al. (2017) Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ER?-Regulated Transcriptional Program. Mol Cell 66:321-331.e6
Puc, Janusz; Aggarwal, Aneel K; Rosenfeld, Michael G (2017) Physiological functions of programmed DNA breaks in signal-induced transcription. Nat Rev Mol Cell Biol 18:471-476
Telese, Francesca; Ma, Qi; Perez, Patricia Montilla et al. (2015) LRP8-Reelin-Regulated Neuronal Enhancer Signature Underlying Learning and Memory Formation. Neuron 86:696-710
Zhang, Feng; Tanasa, Bogdan; Merkurjev, Daria et al. (2015) Enhancer-bound LDB1 regulates a corticotrope promoter-pausing repression program. Proc Natl Acad Sci U S A 112:1380-5
Puc, Janusz; Kozbial, Piotr; Li, Wenbo et al. (2015) Ligand-dependent enhancer activation regulated by topoisomerase-I activity. Cell 160:367-80
Li, Wenbo; Hu, Yiren; Oh, Soohwan et al. (2015) Condensin I and II Complexes License Full Estrogen Receptor ?-Dependent Enhancer Activation. Mol Cell 59:188-202

Showing the most recent 10 out of 61 publications